Kenji Murata

Kenji Murata

Auto-generated profile, based on publicly available information

Kenji Murata

Department of Pathology, Sapporo Medical University

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2020 in eLife
Verified
Journal Article
Open access
KMKenji Murata
Kenji Murata
MNMunehide Nakatsugawa
Munehide Nakatsugawa
MRMuhammed A Rahman
Muhammed A Rahman
LNLinh T Nguyen
Linh T Nguyen
DMDouglas G Millar
Douglas G Millar
NHNaoto Hirano
Naoto Hirano
HLA-restricted T cell responses can induce antitumor effects in cancer patients. Previous human T cell research has largely focused on the few HLA alleles prevalent in a subset of ethnic groups. Here, using a panel of newly developed peptide-exchangeable peptide/HLA multimers and artificial antigen-presenting cells for 25 different class I alleles and greater than 800 peptides, we systematically and comprehensively mapped shared antigenic epitopes recognized by tumor-infiltrating T lymphocytes (TILs) from eight melanoma patients for all their class I alleles. We were able to determine the specificity, on average, of 12.2% of the TILs recognizing a mean of 3.1 shared antigen-derived epitopes across HLA-A, B, and C. Furthermore, we isolated a number of cognate T cell receptor genes with tumor reactivity. Our novel strategy allows for a more complete examination of the immune response and development of novel cancer immunotherapy not limited by HLA allele prevalence or tumor mutation burden.

4 December 2024 in Science Translational Medicine
Verified
Journal Article
Closed access
TMTomoyuki Minowa
Tomoyuki Minowa
KMKenji Murata
Kenji Murata
YMYuka Mizue
Yuka Mizue
AMAiko Murai
Aiko Murai
MNMunehide Nakatsugawa
Munehide Nakatsugawa
Toshihiko TorigoeToshihiko Torigoe
Toshihiko Torigoe
Acral lentiginous melanoma (ALM) is the most common melanoma subtype in non-Caucasians. Despite advances in cancer immunotherapy, current immune checkpoint inhibitors remain unsatisfactory for ALM. Hence, we conducted comprehensive immune profiling using single-cell phenotyping with reactivity screening of the T cell receptors of tumor-infiltrating T lymphocytes (TILs) in ALM. Compared with cutaneous melanoma, ALM showed a lower frequency of tumor-reactive CD8 clusters and an enrichment of regulatory T cells with direct tumor recognition ability, suggesting a suppressive immune microenvironment in ALM. Tumor-reactive CD8 TILs showed heterogeneous expression of coinhibitory molecules, including KLRC1 (NKG2A), in subpopulations with therapeutic implications. Overall, our study provides a foundation for enhancing the efficacy of immunotherapy in ALM.

1 January 2016 in Japanese Journal of Clinical Immunology
Verified
Journal Article
Open access
PDF file
KMKenji Murata
Kenji Murata
TTTomohide Tsukahara
Tomohide Tsukahara
Toshihiko TorigoeToshihiko Torigoe
Toshihiko Torigoe
ヒトには免疫応答を記憶する機構が備わっており,感染症の罹患や重症化を予防する重要な役割を担っている.一方,T細胞の免疫記憶構築システムに関する多くの研究は,マウスモデルを用いて行われている.しかし,ヒトの系とマウスの系では相違点が多く,ヒトにおける免疫記憶機構を解明する必要がある.さらに,腫瘍免疫の分野においても免疫記憶の重要性は指摘されているが,担がん個体では,がん抗原の長期的な暴露によってT細胞は疲弊し,腫瘍抗原特異的なメモリーT細胞が維持されにくいとされている.よって,腫瘍を長期的に拒絶するためには,腫瘍抗原特異的なメモリーT細胞を長期間保持することが肝要である.また,腫瘍に対する養子免疫療法では,分化の進んでいないメモリーT細胞が長く体内に残存して抗腫瘍効果を高めると考えられている.そこで,近年は幹細胞の性質をもったヒトメモリーT細胞集団の養子免疫療法への有効性が期待されている.著者らが同定した新たなヒトメモリーT幹細胞集団は,これまでのメモリーT細胞よりもさらにナイーブT細胞に形質が近く,化学療法耐性といった幹細胞の性質をもつ細胞である.本総説では,この新しいT細胞集団を紹介するとともに,がん免疫療法における免疫記憶の重要性について概説する.

10 December 2024 in Cancer Immunology Research
Verified
Journal Article
Closed access
MFMinami Fusagawa
Minami Fusagawa
STSerina Tokita
Serina Tokita
KMKenji Murata
Kenji Murata
TMTasuku Mariya
Tasuku Mariya
MUMina Umemoto
Mina Umemoto
Toshihiko TorigoeToshihiko Torigoe
Toshihiko Torigoe
Tumor-reactive CD4+ T cells often accumulate in the tumor microenvironment (TME) in human cancer, but their functions and roles in antitumor responses remain elusive. Here, we investigated the immunopeptidome of HLA class II–positive (HLA-II+) endometrial cancer with an inflamed TME using a proteogenomic approach. We identified HLA-II neoantigens, one of which induced polyclonal CD4+ tumor-infiltrating lymphocyte responses. We then experimentally demonstrated that neoantigen-specific CD4+ tumor-infiltrating lymphocytes lyse target cells in an HLA-II–dependent manner. Single-cell transcriptomic analysis of the TME coupled with T-cell receptor sequencing revealed the presence of CD4+ T-cell clusters characterized by CXCL13 expression. The CXCL13+ clusters contained two subclusters with distinct cytotoxic gene expression patterns. The identified neoantigen-specific CD4+ T cells were found exclusively in one of the CXCL13+ subclusters characterized by granzyme B and CCL5 expression. These results demonstrate the involvement of tumor-reactive CD4+ T cells with cytotoxic function in immune surveillance of endometrial cancer and reveal their transcriptomic signature.

15 June 2022 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
KKKoji Kato
Koji Kato
MNMunehide Nakatsugawa
Munehide Nakatsugawa
STSerina Tokita
Serina Tokita
YHYoshihiko Hirohashi
Yoshihiko Hirohashi
TKTerufumi Kubo
Terufumi Kubo
Toshihiko TorigoeToshihiko Torigoe
Toshihiko Torigoe
CD8+ T cells recognize peptides displayed by HLA class I molecules and monitor intracellular peptide pools. It is known that the proteasome splices two short peptide fragments. Recent studies using mass spectrometry (MS) and bioinformatics analysis have suggested that proteasome-generated spliced peptides (PSPs) may account for a substantial proportion of HLA class I ligands. However, the authenticity of the PSPs identified using bioinformatics approaches remain ambiguous. In this study, we employed MS-based de novo sequencing to directly capture cryptic HLA ligands that were not templated in the genome. We identified two PSPs originating from the same protein in a human colorectal cancer line with microsatellite instability. Healthy donor-derived CD8+ T cells readily responded to the two PSPs, showing their natural HLA presentation and antigenicity. Experiments using minigene constructs demonstrated proteasome-dependent processing of two PSPs generated by standard and reverse cis splicing, respectively. Our results suggest a broader diversity of HLA class I Ag repertoires generated by proteasomal splicing, supporting the advantage of MS-based approaches for the comprehensive identification of PSPs. Key Points We performed a comprehensive analysis of PSPs by mass spectrometry–based de novo sequencing. We validated proteasome splicing–dependent HLA presentation using reactive T cells.

15 October 2022 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
KMKenji Murata
Kenji Murata
DLDalam Ly
Dalam Ly
HSHiroshi Saijo
Hiroshi Saijo
YMYukiko Matsunaga
Yukiko Matsunaga
KSKenji Sugata
Kenji Sugata
NHNaoto Hirano
Naoto Hirano
Plasmodiophora brassicae is an obligate biotrophic pathogenic protist responsible for clubroot, a root gall disease of Brassicaceae species. In addition to the reference genome of the P. brassicae European e3 isolate and the draft genomes of Canadian or Chinese isolates, we present the genome of eH, a second European isolate. Refinement of the annotation of the eH genome led to the identification of the mitochondrial genome sequence, which was found to be bigger than that of Spongospora subterranea, another plant parasitic Plasmodiophorid phylogenetically related to P. brassicae. New pathways were also predicted, such as those for the synthesis of spermidine, a polyamine up-regulated in clubbed regions of roots. A P. brassicae pathway genome database was created to facilitate the functional study of metabolic pathways in transcriptomics approaches. These available tools can help in our understanding of the regulation of P. brassicae metabolism during infection and in response to diverse constraints.